Centinel Spine divests spine fusion business

Centinel Spine announced that it entered into a definitive agreement to sell its global spine fusion product portfolio to Silony Medical.

The companies expect the transaction to close within 45 days. The companies declined to disclose the terms of the divestiture of the portfolio and related assets.

West Chester, Pennsylvania–based Centinel Spine says the sale enables it to focus exclusively on its Prodisc total disc replacement (TDR) platform. The company aims to become the global market leader in cervical and lumbar total disc replacement. Its 2022 Prodisc revenue neared $45 million, taking the company to the second spot in the global market, it said.

Centinel Spine reports first-half, year-over-year Prodisc revenue growth of more than 50% in 2023. It attributed some growth to the September launch of the Prodisc C Vivo and Prodisc C SK systems. The divestiture sees Centinel Spine’s Stalif products move to Silony.

“This divestiture al…

Read more
  • 0

Centinel Spine announces first commercial use of total disc replacement portfolio

[Image from Centinel Spine]Centinel Spine announced today that a Texas surgeon completed the first implantation of its Prodisc C VIVO spine implant.

West Chester, Pennsylvania-based Centinel Spine designed the Prodisc C Vivo for cervical total disc replacement (TDR). The company in July received FDA approval for its Prodisc C Vivo, Prodisc C SK and Prodisc C Nova.

Dr. Jason Tinley, orthopedic spine surgeon and founder of the Dallas-Forth Worth Center for Spinal Disorders, performed the first Prodisc C Vivo procedure.

“This patient had severe left-sided neck pain radiating into the forearm and thumb and a left C5/6 disc herniation,” Tinley said in a news release. “Having the intraoperative options of a convex dome with spikes (Prodisc C Vivo) versus a flat endplate component with keel (Prodisc C) gave me the modularity to maximize endplate contact and stability, thus decreasing bone removal, risk of heterotopic ossification, subsidence, or …

Read more
  • 0

Centinel Spine appoints new chief financial officer

Centinel Spine this week said it appointed Varun Gandhi as chief financial officer, effective August 17.

Gandhi succeeds Jeff Stello, who had served as interim chief financial officer since late 2018.

Prior to his appointment, Gandhi served as senior VP of corporate finance and strategic planning and GM of international at Centinel Spine. He previously served as VP of strategic planning and corporate finance at Small Bone Innovations, which was later acquired by Stryker.

“Varun Gandhi is a proven financial, strategic, and organizational leader in the orthopedics industry who has made particularly important contributions to Centinel Spine and its growth over the past several years. He knows our company and the spine market deeply. We look forward to Varun’s contributions to the next phase of growth for Centinel Spine,” CEO Steve Murray said in a news release.

Read more
  • 0